Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FTD vs HD-MTX-Ara-C in PCNSL
NCT05274139Phase 2Completed
- Start
- Mar 2017
- Primary completion
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fotemustine, temozolomide in primary central nervous system lymphoma (PCNSL). Started Mar 2017; status: completed.
02
Drugs
fotemustinetemozolomide
03
Conditions
primary central nervous system lymphoma (PCNSL)
Beyond the preview
Go deeper on NCT05274139.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05274139.